G01N 2333/91265
Polyribonucleotide nucleotidyl transferases, i.e. polynucleotide phosphorylase
Official title: Polyribonucleotide nucleotidyl transferases, i.e. polynucleotide phosphorylase (2.7.7.8)
G01N2333/91265 (Polyribonucleotide nucleotidyl transferases, i.e. polynucleotide phosphorylase) appears on 1 US grants and 5 published applications in this corpus.
Search patents in G01N- Granted patents
- 1
- Published applications
- 5
- Assignees
- 6
- Inventors
- 16
- Latest grant
- 24 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Papd5 inhibitors and methods of use thereof30 Apr 2026US 2026/0115182 A1Children's Medical Center Corporation
- Scalable production of polyribonucleotides of controlled size8 Aug 2024US 2024/0262858 A1Oncovir, Inc.
- Artc1 ligands for cancer treatment18 May 2023US 2023/0151118 A1UniversitäT ZüRich
- Papd5 inhibitors and methods of use thereof17 Jun 2021US 2021/0177827 A1Children's Medical Center Corporation
- Luminescent detection of inorganic phosphate and coupled reactions18 Sep 2014US 2014/0273036 A1Promega Corporation
Most cited
By later US patents